Prestige Ameritech

Last updated
Prestige Ameritech
IndustryManufacturing
Founded2005
FounderDan Reese
Mike Bowen
Headquarters
ProductsSurgical masks
Respirators
Website prestigeameritech.com/home

Prestige Ameritech is an American manufacturer of surgical masks and respirators based in North Richland Hills, Texas. The company produced over a million surgical masks per day during the height of the 2009 swine flu pandemic [1] and rose to prominence again during the COVID-19 pandemic. [2]

Contents

History

Prestige Ameritech was founded in 2005 by Dan Reese and Mike Bowen. [3]

According to a whistleblower complaint by Rick Bright, former director of the Biomedical Advanced Research and Development Authority (BARDA), Prestige Ameritech offered to provide masks in January 2020 but was rebuffed by the Trump administration. [4] Executive Vice President Michael Bowen noted that in the event of a "dire situation", his company could increase production by 1.7 million N95 masks per week by reactivating four N95 manufacturing lines in "like-new" condition at significant cost, but would require a major financial commitment from the government. [2] White House economic adviser Peter Navarro said that "the company was just extremely difficult to work and communicate with." [5]

Ultimately FEMA took over mask acquisition for the government in March, during which Prestige submitted a bid. [2] Bowen went on former White House Chief Strategist Steve Bannon's "War Room" podcast to press his case, [6] and on April 7 Prestige won a $9.5 million FEMA contract to produce a million N95 masks per month over a period of one year at 79 cents apiece, a pace that did not require the company to restart its idle manufacturing lines. [2] This deal was criticized as evidence of favoritism by the Trump administration, as this was only the second time in FEMA's history that a contract was awarded due to direct intervention by the president. [6]

Related Research Articles

<span class="mw-page-title-main">Surgical mask</span> Mouth and nose cover against bacterial aerosols

A surgical mask, also known by other names such as a medical face mask or procedure mask, is a personal protective equipment used by healthcare professionals that serves as a mechanical barrier that interferes with direct airflow in and out of respiratory orifices. This helps reduce airborne transmission of pathogens and other aerosolized contaminants between the wearer and nearby people via respiratory droplets ejected when sneezing, coughing, forceful expiration or unintentionally spitting when talking, etc. Surgical masks may be labeled as surgical, isolation, dental or medical procedure masks.

The Strategic National Stockpile (SNS), originally called the National Pharmaceutical Stockpile (NPS), is the United States' national repository of antibiotics, vaccines, chemical antidotes, antitoxins, and other critical medical supplies. Its website states:

"The Strategic National Stockpile's role is to supplement state and local supplies during public health emergencies. Many states have products stockpiled, as well. The supplies, medicines, and devices for life-saving care contained in the stockpile can be used as a short-term stopgap buffer when the immediate supply of adequate amounts of these materials may not be immediately available."

<span class="mw-page-title-main">Biomedical Advanced Research and Development Authority</span> Government organization in Washington D.C., United States

The Biomedical Advanced Research and Development Authority (BARDA) is a U.S. Department of Health and Human Services (HHS) office responsible for the procurement and development of medical countermeasures, principally against bioterrorism, including chemical, biological, radiological and nuclear (CBRN) threats, as well as pandemic influenza and emerging diseases. BARDA was established in 2006 through the Pandemic and All-Hazards Preparedness Act (PAHPA) and reports to the Office of the Assistant Secretary for Preparedness and Response (ASPR). The office manages Project BioShield, which funds the research, development and stockpiling of vaccines and treatments that the government could use during public health emergencies such as chemical, biological, radiological or nuclear (CBRN) attacks.

<span class="mw-page-title-main">Medline Industries</span> American healthcare company

Medline Industries, LP is an American private healthcare company headquartered in Northfield, Illinois. In June, 2021 it was acquired by a consortium of private equity firms Blackstone, Carlyle and Hellman & Friedman valuing the company at $34 billion in one of the largest leveraged buyouts of all time. It is the nation's largest privately held manufacturer and distributor of medical supplies providing products, education, clinical programs and services across the continuum of care with operations in over 125 countries and territories.

<span class="mw-page-title-main">Robert Kadlec</span> American physician and government official

Robert Peter Kadlec is an American physician and career officer in the United States Air Force who served as Assistant Secretary of Health and Human Services from August 2017 until January 2021. He is responsible for the creation of the COVID-19 vaccine development program Operation Warp Speed.

Steris plc is an American-Irish-based medical equipment company specializing in sterilization and surgical products for the US healthcare system. Steris is operationally headquartered in Mentor, Ohio, but has been legally registered since 2018 in Dublin, Ireland for tax purposes; it was previously registered in the United Kingdom from 2014 to 2018. Steris is quoted on the NYSE, and is a constituent of the S&P 500 Index.

<span class="mw-page-title-main">COVID-19 pandemic in the United States</span>

On December 31, 2019, China announced the discovery of a cluster of pneumonia cases in Wuhan. The first American case was reported on January 20, and Health and Human Services Secretary Alex Azar declared a public health emergency on January 31. Restrictions were placed on flights arriving from China, but the initial U.S. response to the pandemic was otherwise slow in terms of preparing the healthcare system, stopping other travel, and testing. The first known American deaths occurred in February and in late February President Donald Trump proposed allocating $2.5 billion to fight the outbreak. Instead, Congress approved $8.3 billion with only Senator Rand Paul and two House representatives voting against, and Trump signed the bill, the Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020, on March 6. Trump declared a national emergency on March 13. The government also purchased large quantities of medical equipment, invoking the Defense Production Act of 1950 to assist. By mid-April, disaster declarations were made by all states and territories as they all had increasing cases. A second wave of infections began in June, following relaxed restrictions in several states, leading to daily cases surpassing 60,000. By mid-October, a third surge of cases began; there were over 200,000 new daily cases during parts of December 2020 and January 2021.

<span class="mw-page-title-main">N95 respirator</span> Particulate respirator meeting the N95 standard

An N95 respirator is a disposable filtering facepiece respirator or reusable elastomeric respirator filter that meets the U.S. National Institute for Occupational Safety and Health (NIOSH) N95 standard of air filtration, filtering at least 95% of airborne particles that have a mass median aerodynamic diameter of 0.3 micrometers under 42 CFR 84, effective July 10, 1995. A surgical N95 is also rated against fluids, and is regulated by the US Food and Drug Administration under 21 CFR 878.4040, in addition to NIOSH 42 CFR 84. 42 CFR 84, the federal standard which the N95 is part of, was created to address shortcomings in the prior United States Bureau of Mines respirator testing standards, as well as tuberculosis outbreaks, caused by the HIV/AIDS epidemic in the United States. Since then, N95 respirator has continued to be solidified as a source control measure in various pandemics that have been experienced in the United States and Canada, including the 2009 swine flu and the COVID-19 pandemic.

<span class="mw-page-title-main">Shortages related to the COVID-19 pandemic</span> Medical material and other goods shortages caused by the COVID-19 pandemic

Shortages related to the COVID-19 pandemic are pandemic-related disruptions to goods production and distribution, insufficient inventories, and disruptions to workplaces caused by infections and public policy.

<span class="mw-page-title-main">Responses to the COVID-19 pandemic in April 2020</span> Sequence of major events in a virus pandemic

This article documents the chronology of the response to the COVID-19 pandemic in April 2020, which originated in Wuhan, China in December 2019. Some developments may become known or fully understood only in retrospect. Reporting on this pandemic began in December 2019.

Planning and preparing for pandemics has happened in countries and international organizations. The World Health Organization writes recommendations and guidelines, though there is no sustained mechanism to review countries' preparedness for epidemics and their rapid response abilities. National action depends on national governments. In 2005–2006, before the 2009 swine flu pandemic and during the decade following it, the governments in the United States, France, UK, and others managed strategic health equipment stocks, but they often reduced stocks after the 2009 pandemic in order to reduce costs.

<span class="mw-page-title-main">Face masks during the COVID-19 pandemic</span> Health control procedure against COVID-19

During the COVID-19 pandemic, face masks or coverings, including N95, FFP2, surgical, and cloth masks, have been employed as public and personal health control measures against the spread of SARS-CoV-2, the virus that causes COVID-19.

<span class="mw-page-title-main">Communication of the Trump administration during the COVID-19 pandemic</span> Aspect of 2020 viral outbreak

The Donald Trump administration communicated in various ways during the COVID-19 pandemic in the United States, including via social media, interviews, and press conferences with the White House Coronavirus Task Force. Opinion polling conducted in mid-April 2020 indicated that less than half of Americans trusted health information provided by Trump and that they were more inclined to trust local government officials, state government officials, the Centers for Disease Control and Prevention (CDC), and National Institute of Allergy and Infectious Diseases director Anthony Fauci.

<span class="mw-page-title-main">Rick Bright</span> American immunologist and whisteblower

Rick Arthur Bright is an American immunologist, vaccine researcher, and public health official. He was the director of the Biomedical Advanced Research and Development Authority (BARDA) from 2016 to 2020. In May 2020, he filed a whistleblower complaint, alleging that the Trump administration ignored his early warnings about the COVID-19 pandemic and illegally retaliated against him by ousting him from his role and demoting him to a position at the National Institutes of Health. On October 6, 2020, Bright resigned from the government. On November 9 he was named a member of President-elect Joe Biden's coronavirus advisory board.

<span class="mw-page-title-main">Source control (respiratory disease)</span> Strategy for reducing disease transmission

Source control is a strategy for reducing disease transmission by blocking respiratory secretions produced through breathing, speaking, coughing, sneezing or singing. Multiple source control techniques can be used in hospitals, but for the general public wearing personal protective equipment during epidemics or pandemics, respirators provide the greatest source control, followed by surgical masks, with cloth face masks recommended for use by the public only when there are shortages of both respirators and surgical masks.

<span class="mw-page-title-main">Face masks during the COVID-19 pandemic in the United States</span> US Health control procedure against COVID-19

The wearing of non-medical face masks in public to lessen the transmission of COVID-19 in the United States was first recommended by the CDC on April 3, 2020, as supplemental to hygiene and appropriate social distancing. Throughout the pandemic, various states, counties, and municipalities have issued health orders requiring the wearing of non-medical face coverings — such as cloth masks — in spaces and businesses accessible to the public, especially when physical distancing is not possible.

Matthew Maxwell Taylor Kennedy Jr. is an American government volunteer, political organizer, and member of the Kennedy family. He is the whistleblower who sent a complaint to the United States House Committee on Oversight and Reform regarding the White House Coronavirus Task Force, which he worked on as a volunteer. Kennedy worked for the Democratic Party on their 2020 campaign efforts.

<span class="mw-page-title-main">United States responses to the COVID-19 pandemic</span>

The United States' response to the COVID-19 pandemic with consists of various measures by the medical community; the federal, state, and local governments; the military; and the private sector. The public response has been highly polarized, with partisan divides being observed and a number of concurrent protests and unrest complicating the response.

<span class="mw-page-title-main">Aid and relief efforts during the COVID-19 pandemic in Malaysia</span>

The Government of Malaysia along with various non governmental organisations (NGOs), companies, and foreign governments introduced various financial aid and relief programs in response to the economic impacts of the COVID-19 pandemic in Malaysia. On 27 March 2020, Prime Minister Muhyiddin Yassin introduced an economic stimulus package known as the Prihatin worth RM250 billion.

The American Medical Manufacturers Association, formerly the American Mask Manufacturers Association, (AMMA) is an organization formed to promote strategic mask, respirator, and Personal Protective Equipment (PPE) manufacturing in the United States.

References

  1. Lavandera, Ed (30 April 2009). "Flu has sole U.S. surgical mask producer scrambling". CNN. Archived from the original on 7 May 2009. Retrieved 10 May 2020.
  2. 1 2 3 4 Davis, Aaron C. (9 May 2020). "In the early days of the pandemic, the U.S. government turned down an offer to manufacture millions of N95 masks in America". The Washington Post. Retrieved 10 May 2020.
  3. Davis, Aaron C. (2020-05-11). "In the early days of the pandemic, the U.S. government turned down an offer to manufacture millions of N95 masks in America". Washington Post. ISSN   0190-8286 . Retrieved 2024-08-15.
  4. Lerner, Sharon (7 May 2020). "Whistleblower Details How Trump's Bureaucrats Refused to Secure N95 Masks as Pandemic Loomed". The Intercept. Retrieved 10 May 2020.
  5. Beggin, Riley (10 May 2020). "Trump administration reportedly refused a January offer for millions of US-made N95 masks". Vox. Retrieved 15 May 2020.
  6. 1 2 Allen, Jonathan; McCausland, Phil; Farivar, Cyrus (24 April 2020). "Want a mask contract or some ventilators? A White House connection helps". NBC News. Retrieved 10 May 2020.